Back to search

Molecular Oncology Limited

08483710

active
Private Limited Company
england wales
Companies House
Health Score
90 / 100

Healthy

30/30
Filing
20/30
Financial
40/40
Risk

No risk factors detected.

Details

2 ST. MARYS ROAD, TONBRIDGE, TN9 2LB
Incorporated 11/04/2013

Compliance

Last accounts

30/04/2025

micro entity

Next accounts due

31/01/2027

On track

Confirmation statement

Last: 11/04/2026

Due 25/04/2027

On track

Industry

86220
Specialist medical practice activities

Officers

Dr Robert Charles Swanton

director · Since 11/04/2013

DOCTOR

BRITISH · ENGLAND · Age 54

Persons with Significant Control

Dr Robert Charles Swanton

75–100% shares
75–100% votes
Appoint directors

British · England · Age 54

2, St Mary's Road, Tonbridge, TN9 2LB

Notified 06/04/2017

Former PSCs

Dr Brianna Tracey Cloke

Ceased 31/08/2025

CompanyRankvs 333+ SIC 86220 peers
85

Financial strength94th percentile among SIC peers · 24/25
Employees87th percentile among SIC peers · 13/15
LiquidityCurrent ratio 45.47× · 20/20
Longevity13 years trading (max 15) · 13/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength24/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees13/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity13/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 30/04/2025

Net Worth

£543k

Balance sheet strength

Cash

Cash in the bank

Net Current Assets

£494k

Working capital

Current Assets

£505k

Current Liabilities

£11k

Fixed Assets

£49k

3avg. employees

Balance Sheet

Assets less current liabilities£543k
Prepared with IRIS Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
202545.47+£46k
202411.57+£94k
202318.47+£95k
202211.51+£78k
20216.84+£65k
20202.41+£62k
20194.88+£57k
20182.65

Derived from filed accounts. Not audited figures.